Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive CofiledCriticalColgate Palmolive Co
Priority to MYPI20113871priorityCriticalpatent/MY152565A/en
Publication of MY152565ApublicationCriticalpatent/MY152565A/en
AN ORAL COMPOSITION EXHIBITING INCREASED UPTAKE BY DENTAL TISSUE OF ANTIBACTERIAL COMPOUNDS CONTAINED THEREIN AND ELIMINATING OR SUBSTANTIALLY REDUCING THE DISCOMFORT AND PAIN ASSOCIATED WITH DENTINAL HYPERSENSITIVITY. THE COMPOSITION INCLUDES AN ORALLY ACCEPTABLE VEHICLE FOR SUCH COMPOSITION, AN EFFECTIVE THERAPEUTIC AMOUNT OF AN ANTIBACTERIAL COMPOUND, A MIXTURE OF ANIONIC SURFACTANT AND AMPHOTERIC SURFACTANT, THE MIXTURE HAVING 0.1 WT. % TO 2.0 WT. % ANIONIC SURFACTANT AND 0.8 WT. % TO 2.0 WT. % AMPHOTERIC SURFACTANT, AND A POTASSIUM ION RELEASABLE COMPOUND.
APPLICATION OF A COMBINATION OF Baclofen AND ACOMPROSAT FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND A COMPOSITION CONTAINING Baclofen AND ACAMPROSAT
Composition for oral care comprising a fundamental amino acid; a fraction of small particles and an antimicrobial agent and its use to reduce or prevent dental caries, enamel lesions, demineralization, dental hypersensitivity, gingivitis, among others.